TY - JOUR
T1 - Generic outcome set for the international registry on Laser trEAtments in Dermatology (LEAD)
T2 - A protocol for a Delphi study to achieve consensus on what to measure
AU - Fransen, Frederike
AU - Spuls, Phyllis
AU - Alam, Murad
AU - Alam, Murad
AU - Badawi, Ashraf
AU - Boixeda, Pablo
AU - Haedersdal, Merete
AU - Haedersdal, Merete
AU - Hamzavi, Iltefat
AU - Hedelund, Lene
AU - Kelly, Kristen M.
AU - Kono, Tara
AU - Laubach, Hans Joachim
AU - Manuskiatti, Woraphong
AU - Marini, Leonardo
AU - Nouri, Keyvan
AU - Paasch, Uwe
AU - Passeron, Thierry
AU - Prinsen, Cecilia A.C.
AU - Verner, Ines
AU - Wolkerstorfer, Albert
PY - 2020/6/28
Y1 - 2020/6/28
N2 - Introduction While laser technology has expanded the armamentarium of treatment for various skin diseases during the past years, heterogeneity in study outcomes hampers comparability and appropriate evidence synthesis. Part of these issues can be addressed by developing a generic outcome set. Using the Delphi method, this study aims to seek consensus between key stakeholders on relevant generic outcomes (what to measure) for implementation in the international registry on Laser trEAtments in Dermatology (LEAD). The registry is focused on collecting research data on various laser treatments for skin disorders. Methods and analysis By reviewing the literature and involvement of key stakeholder groups and adult patients in need or after laser surgery and health professionals, a preliminary list of outcomes will be generated and categorised into domains. Using these outcomes, an international three-round Delphi study will be performed to rate the importance of outcomes in the selection of a generic outcome set. Participants are allowed to provide new outcomes to the preliminary list for revisions during the first Delphi round. Finally, results will be discussed during a consensus meeting to agree on generic outcomes to be used in the LEAD registry. Ethics and dissemination An ethics approval was not applicable (W19_290 # 18.336). The study is registered with the Cochrane Skin Core OUtcome Set INitiative) and the Core Outcome Measures in Effectiveness Trials initiative. Procedures will be conducted according to the Declaration of Helsinki. The findings will be disseminated through peer-reviewed publications and conference presentations.
AB - Introduction While laser technology has expanded the armamentarium of treatment for various skin diseases during the past years, heterogeneity in study outcomes hampers comparability and appropriate evidence synthesis. Part of these issues can be addressed by developing a generic outcome set. Using the Delphi method, this study aims to seek consensus between key stakeholders on relevant generic outcomes (what to measure) for implementation in the international registry on Laser trEAtments in Dermatology (LEAD). The registry is focused on collecting research data on various laser treatments for skin disorders. Methods and analysis By reviewing the literature and involvement of key stakeholder groups and adult patients in need or after laser surgery and health professionals, a preliminary list of outcomes will be generated and categorised into domains. Using these outcomes, an international three-round Delphi study will be performed to rate the importance of outcomes in the selection of a generic outcome set. Participants are allowed to provide new outcomes to the preliminary list for revisions during the first Delphi round. Finally, results will be discussed during a consensus meeting to agree on generic outcomes to be used in the LEAD registry. Ethics and dissemination An ethics approval was not applicable (W19_290 # 18.336). The study is registered with the Cochrane Skin Core OUtcome Set INitiative) and the Core Outcome Measures in Effectiveness Trials initiative. Procedures will be conducted according to the Declaration of Helsinki. The findings will be disseminated through peer-reviewed publications and conference presentations.
KW - dermatology
KW - laser therapy
KW - surgical dermatology
UR - http://www.scopus.com/inward/record.url?scp=85087253924&partnerID=8YFLogxK
U2 - https://doi.org/10.1136/bmjopen-2020-038145
DO - https://doi.org/10.1136/bmjopen-2020-038145
M3 - Article
C2 - 32595165
SN - 2044-6055
VL - 10
SP - e038145
JO - BMJ Open
JF - BMJ Open
IS - 6
M1 - e038145
ER -